412 related articles for article (PubMed ID: 21050765)
1. Persistence of human papillomavirus infection: keys to malignant progression.
Bodily J; Laimins LA
Trends Microbiol; 2011 Jan; 19(1):33-9. PubMed ID: 21050765
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
Chakrabarti O; Krishna S
J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Richart RM; Masood S; Syrjänen KJ; Vassilakos P; Kaufman RH; Meisels A; Olszewski WT; Sakamoto A; Stoler MH; Vooijs GP; Wilbur DC
Acta Cytol; 1998; 42(1):50-8. PubMed ID: 9479323
[TBL] [Abstract][Full Text] [Related]
5. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of cervical cancer.
Ibeanu OA
Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus proteins as prospective therapeutic targets.
Pang CL; Thierry F
Microb Pathog; 2013 May; 58():55-65. PubMed ID: 23164805
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.
Scarth JA; Patterson MR; Morgan EL; Macdonald A
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33427604
[TBL] [Abstract][Full Text] [Related]
9. Persistent human papillomavirus infection and cervical neoplasia.
Ferenczy A; Franco E
Lancet Oncol; 2002 Jan; 3(1):11-6. PubMed ID: 11905599
[TBL] [Abstract][Full Text] [Related]
10. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
11. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India.
Pillai RM; Babu JM; Jissa VT; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Reddy KB; Chakka KN; Siddiqui M; Roychoudury S; Abraham P; Peedicayil A; Gnanamony M; Subashini J; Ram TS; Dey B; Singh N; Singh A; Jain SK; Jayshree RS
Int J Gynecol Cancer; 2010 Aug; 20(6):1046-51. PubMed ID: 20683415
[TBL] [Abstract][Full Text] [Related]
12. HPV post-infection microenvironment and cervical cancer.
Yuan Y; Cai X; Shen F; Ma F
Cancer Lett; 2021 Jan; 497():243-254. PubMed ID: 33122098
[TBL] [Abstract][Full Text] [Related]
13. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.
Al Moustafa AE
Cell Adh Migr; 2015; 9(5):392-3. PubMed ID: 26177717
[TBL] [Abstract][Full Text] [Related]
14. Cancer associated human papillomaviruses.
McLaughlin-Drubin ME; Meyers J; Munger K
Curr Opin Virol; 2012 Aug; 2(4):459-66. PubMed ID: 22658985
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
16. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
[TBL] [Abstract][Full Text] [Related]
17. Human papillomaviruses and their role in cervical cancer.
Dell G; Gaston K
Cell Mol Life Sci; 2001 Nov; 58(12-13):1923-42. PubMed ID: 11766888
[TBL] [Abstract][Full Text] [Related]
18. [Current advances in the mechanic studies of human papillomavirus-induced oncogenesis].
Zhou XB; Xu NZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):673-7. PubMed ID: 18051727
[TBL] [Abstract][Full Text] [Related]
19. The low-risk papillomaviruses.
Egawa N; Doorbar J
Virus Res; 2017 Mar; 231():119-127. PubMed ID: 28040475
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
